Search

Author/Creator Laubach, Jacob P

1. Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial. Issue 6 (June 2022)

Authors:
Dimopoulos, Meletios A; Richardson, Paul G; Bahlis, Nizar J; Grosicki, Sebastian; Cavo, Michele; Beksaç, Meral; Legieć, Wojciech; Liberati, Anna M; Goldschmidt, Hartmut; Belch, Andrew; Magen, Hila; Larocca, Alessandra; Laubach, Jacob P; Petrucci, Maria T; Reece, Donna; White, Darrell; Mateos, Mar...
Journal:
Lancet
Issue:
Volume 9:Issue 6(2022)
Page Start:
e403
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma: final results from the phase 2 GEN501 and SIRIUS trials. Issue 6 (June 2020)

Authors:
Usmani, Saad Z; Nahi, Hareth; Plesner, Torben; Weiss, Brendan M; Bahlis, Nizar J; Belch, Andrew; Voorhees, Peter M; Laubach, Jacob P; van de Donk, Niels W C J; Ahmadi, Tahamtan; Uhlar, Clarissa M; Wang, Jianping; Feng, Huaibao; Qi, Ming; Richardson, Paul G; Lonial, Sagar
Journal:
Lancet
Issue:
Volume 7:Issue 6(2020)
Page Start:
e447
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Efficacy and safety of oral panobinostat plus subcutaneous bortezomib and oral dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma (PANORAMA 3): an open-label, randomised, phase 2 study. Issue 1 (January 2021)

Authors:
Laubach, Jacob P; Schjesvold, Fredrik; Mariz, Mário; Dimopoulos, Meletios A; Lech-Maranda, Ewa; Spicka, Ivan; Hungria, Vania T M; Shelekhova, Tatiana; Abdo, Andre; Jacobasch, Lutz; Polprasert, Chantana; Hájek, Roman; Illés, Árpád; Wróbel, Tomasz; Sureda, Anna; Beksac, Meral; Gonçalves, Iara Z; Bl...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 1(2021)
Page Start:
142
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Panobinostat: a novel pan-deacetylase inhibitor for the treatment of relapsed or relapsed and refractory multiple myeloma. Issue 7 (July 2015)

Authors:
Richardson, Paul G; Laubach, Jacob P; Lonial, Sagar; Moreau, Philippe; Yoon, Sung-Soo; Hungria, Vânia TM; Dimopoulos, Meletios A; Beksac, Meral; Alsina, Melissa; San-Miguel, Jesús F
Journal:
Expert review of anticancer therapy
Issue:
Volume 15:Issue 7(2015)
Page Start:
737
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Pomalidomide for the treatment of relapsed and refractory multiple myeloma. (October 2014)

Authors:
Guidetti, Anna; Paba Prada, Claudia; Laubach, Jacob P; Varga, Cindy; Maglio, Michelle E; McKenney, Mary; Doss, Deborah; Schlossman, Robert L; Mitsiades, Constantine; Hideshima, Teru; Görgün, Güllü T; Ghobrial, Irene M; Raje, Noopur; Munshi, Nikhil; Anderson, Kenneth C; Richardson, Paul G
Journal:
Expert opinion on orphan drugs
Issue:
Volume 2:Number 10(2014:Oct.)
Page Start:
1089
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗